Evidence map›Paper›PMID 23723346›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Neurovascular coupling to D2/D3 dopamine receptor occupancy using simultaneous PET/functional MRI.

Christin Y Sander, Jacob M Hooker, Ciprian Catana, Marc D Normandin, Nathaniel M Alpert, Gitte M Knudsen, Wim Vanduffel, Bruce R Rosen, Joseph B Mandeville

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 139 citations in OpenAlex.

  1. Antipsychotics cause reversible structural brain changes within one week.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Trial
  2. Brain connectivity changes to fast versus slow dopamine increases.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Trial
  3. Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Trial
  4. When does post-ingestive dopamine signaling occur in humans?bioRxiv : the preprint server for biology · 2026
    Article
  5. Robust changes in brain function require high DNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. PET-MRI Applications and Future Prospects in Psychiatry.Journal of magnetic resonance imaging : JMRI · 2025
    Review
  11. Article
  12. Amphetamine-induced dopamine release in rat: Whole-brain spatiotemporal analysis with [Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  13. Article
  14. Article
  15. Examining the role of dopamine in methylphenidate's effects on resting brain function.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Christin Y SanderAthinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA 02129, USA. csander@mit.edu
Jacob M Hooker
Ciprian Catana
Marc D Normandin
Nathaniel M Alpert
Gitte M Knudsen
Wim Vanduffel
Bruce R Rosen
Joseph B Mandeville
Massachusetts General Hospital · USAthinoula A. Martinos Center for Biomedical Imaging · USRigshospitalet · DK

Funding

ULTRAHIGH FIELD TECHNOLOGY FOR FUNCTIONAL IMAGINGP41RR014075 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI FISCHL, BRUCE · 1999 to 2011
$16.4M
Project 4P41EB015896 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI ROSEN, BRUCE R · 2012 to 2018
$9.8M
Advanced Multimodal Neuroimaging Training GrantR90DA023427 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI ROSEN, BRUCE R · 2006 to 2015
$2.8M
Combined PET and fMRI imaging of dopamine and serotonin responses in depressionR01MH100350 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI NORMANDIN, MARC DAVID · 2013 to 2017
$2.6M
Combined MRI/PET Imager for Simultaneous Acquisition of PET/MRI DataS10RR022976 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI JENKINS, BRUCE · 2007 to 2007
$2.0M
Radiochemist for Drug Abuse PET Probe DevelopmentP30DA028800 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI ROSEN, BRUCE R · 2009 to 2010
$1.4M
PET CAMERA FOR BRAIN IMAGING: SCHIZOPHRENIA, BIPOLAR DISORDERS10RR019933 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI SORENSEN, ALMA GREGORY · 2006 to 2006
$500k
CYCLOTRON &RADIOCHEMISTRY: SUBSTANCE ABUSE, COCAINE, OPIOIDS10RR017208 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI ROSEN, BRUCE R · 2004 to 2004
$500k
Carbon-11 Radiopharmaceutical Production SystemS10RR026666 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI BROWNELL, ANNA-LIISA · 2010 to 2010
$462k
NCRR NIH HHS P41 RR014075NCRR NIH HHS P41RR14075NCRR NIH HHS S10 RR017208NCRR NIH HHS S10RR017208NCRR NIH HHS S10 RR019933NCRR NIH HHS S10RR019933NCRR NIH HHS S10 RR022976NCRR NIH HHS S10RR022976NCRR NIH HHS S10 RR026666NCRR NIH HHS S10RR026666NIDA NIH HHS P30 DA028800NIDA NIH HHS P30DA28800NIDA NIH HHS R90 DA023427NIDA NIH HHS R90DA023427
6 · The paper itself

Abstract

This study employed simultaneous neuroimaging with positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) to demonstrate the relationship between changes in receptor occupancy measured by PET and changes in brain activity inferred by fMRI. By administering the D2/D3 dopamine receptor antagonist [(11)C]raclopride at varying specific activities to anesthetized nonhuman primates, we mapped associations between changes in receptor occupancy and hemodynamics [cerebral blood volume (CBV)] in the domains of space, time, and dose. Mass doses of raclopride above tracer levels caused increases in CBV and reductions in binding potential that were localized to the dopamine-rich striatum. Moreover, similar temporal profiles were observed for specific binding estimates and changes in CBV. Injection of graded raclopride mass doses revealed a monotonic coupling between neurovascular responses and receptor occupancies. The distinct CBV magnitudes between putamen and caudate at matched occupancies approximately matched literature differences in basal dopamine levels, suggesting that the relative fMRI measurements reflect basal D2/D3 dopamine receptor occupancy. These results can provide a basis for models that relate dopaminergic occupancies to hemodynamic changes in the basal ganglia. Overall, these data demonstrate the utility of simultaneous PET/fMRI for investigations of neurovascular coupling that correlate neurochemistry with hemodynamic changes in vivo for any receptor system with an available PET tracer.

Indexed as

AnimalsBrainCerebrovascular CirculationDopamine AntagonistsDopamine D2 Receptor AntagonistsMacaca mulattaMagnetic Resonance ImagingMaleModels, NeurologicalPositron-Emission TomographyRacloprideReceptors, Dopamine D2Receptors, Dopamine D3Dopamine AntagonistsDopamine D2 Receptor AntagonistsRacloprideReceptors, Dopamine D2Receptors, Dopamine D3displacementdynamic binding potentialmonkeyNHP

Identifiers

PMID23723346
PMCPMC3703969
OpenAlexW1980882035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.